Email Updates

You are here

Webinar & Meeting Reports

  • November 3, 2013 to November 5, 2013

    This inaugural translational medicine conference: What Will it Take to Achieve an AIDS-Free World?, which will bring the audiences and editors of The Lancet and Cell together to bridge the gap between clinicians and researchers focused on understanding, managing, preventing and curing HIV/AIDS.

  • October 28, 2013

    The second in a series of webinars by the US Women and PrEP Working Group discussed the possibilities and challenges associated with serodiscordant couples using PrEP to help them achieve pregnancy safely.

  • October 7, 2013

    AIDS Vaccine 2013 took place from October 7–10 in Barcelona, Spain. AIDS Vaccine is the largest global scientific conference focused exclusively on AIDS vaccine research. Hosted annually by the Global HIV Vaccine Enterprise and local partners, AIDS Vaccine brings together the best and brightest scientific minds to exchange the latest research findings, explore new ideas, educate future leaders and engage a diverse community to help further research to develop a safe and effective HIV vaccine.

  • September 16, 2013

    The US Women and PrEP Working Group held a webinar to discuss the latest in research and rollout of PrEP for women in the US. To learn more about the US Women and PrEP Working Group (and hear about upcoming webinars), visit

  • September 12, 2013

    The seventh webinar in our series addressing a range of topics in HIV prevention research, hosted jointly by NAM and AVAC, will focus on rectal microbicides. The presentation was followed by a Q&A session.

  • September 7, 2013 to September 11, 2013

    Thousands of community leaders, front-line workers, policy makers, physicians and advocates from throughout the US met for the United States Conference on AIDS (USCA). What follows is a short list of biomedical HIV prevention research and implementation-related sessions and links to the Black Treatment Action Network/PxROAR Advocates’ Roadmap and full conference program. (The Black Treatment Action Network is a project of the Black AIDS Institute.)

  • August 6, 2013

    On June 30, the World Health Organization (WHO) released updated Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. AVAC, Global Network of People of Living with HIV (GNP+), the International HIV/AIDS Alliance (Alliance), and STOP AIDS NOW! (SAN!) held a webinar to discuss the guidelines and a new tool—Community Guide to Treatment as Prevention Programming.

  • July 23, 2013

    The sixth webinar in our series addressing a range of topics in HIV prevention research, hosted jointly by NAM and AVAC, will focus on the next generation of male and female condoms being introduced to meet specific HIV prevention needs.

  • June 30, 2013 to July 3, 2013

    Held every two years, the IAS Conference on HIV Pathogenesis, Treatment and Prevention includes many sessions on a range of HIV-related topics. Approximately 4,000 scientists, community leaders, public health experts and advocates met between June 30-July 3 in the Kuala Lumpur Convention Center.

  • June 18, 2013

    AVAC and the Harm Reduction Coalition organized a teleconference to discuss the recent results of the Bangkok Tenofovir Study, a Thai trial of pre-exposure prophylaxis in injecting drug users.